Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Pazopanib Market Report 2016

  • QYR679252
  • 123 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Pazopanib

Revenue, means the sales value of Pazopanib

This report studies sales (consumption) of Pazopanib in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Pfizer

Allergan

Alnylam Pharmaceuticals

Amgen

Angstrom Pharmaceuticals

Acceleron Pharma

Biocon

Bionomics

CASI Pharmaceuticals

Celgene Corporation

Enzon Pharmaceuticals

Five Prime Therapeutics

Fujifilm Kyowa Kirin Biologics

Genentech

Genexine

Hetero Drugs

ImClone Systems

Intas Pharmaceuticals

Kyowa Hakko Kirin

Levolta Pharmaceuticals

Mabtech

Marsala Biotech

Neumedicines

Novartis

Oncobiologics

Onyx Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Pazopanib in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Pazopanib Market Report 2016

1 Pazopanib Overview

1.1 Product Overview and Scope of Pazopanib

1.2 Classification of Pazopanib

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Pazopanib

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Pazopanib (2011-2021)

1.4.1 USA Pazopanib Sales and Growth Rate (2011-2021)

1.4.2 USA Pazopanib Revenue and Growth Rate (2011-2021)

2 USA Pazopanib Competition by Manufacturers

2.1 USA Pazopanib Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Pazopanib Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Pazopanib Average Price by Manufactures (2015 and 2016)

2.4 Pazopanib Market Competitive Situation and Trends

2.4.1 Pazopanib Market Concentration Rate

2.4.2 Pazopanib Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Pazopanib Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Pazopanib Sales and Market Share by Type (2011-2016)

3.2 USA Pazopanib Revenue and Market Share by Type (2011-2016)

3.3 USA Pazopanib Price by Type (2011-2016)

3.4 USA Pazopanib Sales Growth Rate by Type (2011-2016)

4 USA Pazopanib Sales (Volume) by Application (2011-2016)

4.1 USA Pazopanib Sales and Market Share by Application (2011-2016)

4.2 USA Pazopanib Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Pazopanib Manufacturers Profiles/Analysis

5.1 Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Pazopanib Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Allergan

5.2.2 Pazopanib Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Allergan Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Alnylam Pharmaceuticals

5.3.2 Pazopanib Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Alnylam Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Amgen

5.4.2 Pazopanib Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Amgen Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Angstrom Pharmaceuticals

5.5.2 Pazopanib Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Angstrom Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Acceleron Pharma

5.6.2 Pazopanib Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Acceleron Pharma Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Biocon

5.7.2 Pazopanib Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Biocon Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bionomics

5.8.2 Pazopanib Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bionomics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 CASI Pharmaceuticals

5.9.2 Pazopanib Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 CASI Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Celgene Corporation

5.10.2 Pazopanib Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Celgene Corporation Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Enzon Pharmaceuticals

5.12 Five Prime Therapeutics

5.13 Fujifilm Kyowa Kirin Biologics

5.14 Genentech

5.15 Genexine

5.16 Hetero Drugs

5.17 ImClone Systems

5.18 Intas Pharmaceuticals

5.19 Kyowa Hakko Kirin

5.20 Levolta Pharmaceuticals

5.21 Mabtech

5.22 Marsala Biotech

5.23 Neumedicines

5.24 Novartis

5.25 Oncobiologics

5.26 Onyx Pharmaceuticals

6 Pazopanib Manufacturing Cost Analysis

6.1 Pazopanib Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Pazopanib

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Pazopanib Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Pazopanib Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Pazopanib Market Forecast (2016-2021)

10.1 USA Pazopanib Sales, Revenue Forecast (2016-2021)

10.2 USA Pazopanib Sales Forecast by Type (2016-2021)

10.3 USA Pazopanib Sales Forecast by Application (2016-2021)

10.4 Pazopanib Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Pazopanib

Table Classification of Pazopanib

Figure USA Sales Market Share of Pazopanib by Type in 2015

Table Application of Pazopanib

Figure USA Sales Market Share of Pazopanib by Application in 2015

Figure USA Pazopanib Sales and Growth Rate (2011-2021)

Figure USA Pazopanib Revenue and Growth Rate (2011-2021)

Table USA Pazopanib Sales of Key Manufacturers (2015 and 2016)

Table USA Pazopanib Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Pazopanib Sales Share by Manufacturers

Figure 2016 Pazopanib Sales Share by Manufacturers

Table USA Pazopanib Revenue by Manufacturers (2015 and 2016)

Table USA Pazopanib Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Pazopanib Revenue Share by Manufacturers

Table 2016 USA Pazopanib Revenue Share by Manufacturers

Table USA Market Pazopanib Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Pazopanib Average Price of Key Manufacturers in 2015

Figure Pazopanib Market Share of Top 3 Manufacturers

Figure Pazopanib Market Share of Top 5 Manufacturers

Table USA Pazopanib Sales by Type (2011-2016)

Table USA Pazopanib Sales Share by Type (2011-2016)

Figure USA Pazopanib Sales Market Share by Type in 2015

Table USA Pazopanib Revenue and Market Share by Type (2011-2016)

Table USA Pazopanib Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Pazopanib by Type (2011-2016)

Table USA Pazopanib Price by Type (2011-2016)

Figure USA Pazopanib Sales Growth Rate by Type (2011-2016)

Table USA Pazopanib Sales by Application (2011-2016)

Table USA Pazopanib Sales Market Share by Application (2011-2016)

Figure USA Pazopanib Sales Market Share by Application in 2015

Table USA Pazopanib Sales Growth Rate by Application (2011-2016)

Figure USA Pazopanib Sales Growth Rate by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Pazopanib Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Pazopanib Sales Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alnylam Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Pazopanib Sales Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Angstrom Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Acceleron Pharma Pazopanib Sales Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon Pazopanib Sales Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bionomics Pazopanib Sales Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table CASI Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Corporation Pazopanib Sales Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Enzon Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Five Prime Therapeutics Pazopanib Sales Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Pazopanib Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Pazopanib Sales Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genexine Pazopanib Sales Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hetero Drugs Pazopanib Sales Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table ImClone Systems Pazopanib Sales Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Intas Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kyowa Hakko Kirin Pazopanib Sales Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Levolta Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mabtech Pazopanib Sales Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Marsala Biotech Pazopanib Sales Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neumedicines Pazopanib Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Pazopanib Sales Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oncobiologics Pazopanib Sales Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Onyx Pharmaceuticals Pazopanib Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Pazopanib

Figure Manufacturing Process Analysis of Pazopanib

Figure Pazopanib Industrial Chain Analysis

Table Raw Materials Sources of Pazopanib Major Manufacturers in 2015

Table Major Buyers of Pazopanib

Table Distributors/Traders List

Figure USA Pazopanib Production and Growth Rate Forecast (2016-2021)

Figure USA Pazopanib Revenue and Growth Rate Forecast (2016-2021)

Table USA Pazopanib Production Forecast by Type (2016-2021)

Table USA Pazopanib Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390